i-Ome® Discovery Functional Protein Microarray Services
Bioinformatics and Protein Array Services
i-Ome Discovery Protein Microarray
Receive your quote directly from the manufacturer.
Using the i-Ome® Discovery Protein Array, Sengenics can profile against more than 1,800 autoimmune- and cancer-related proteins in one assay. This is ideal for discovery studies involving a range of protein types, including: kinases, transcription factors, signaling proteins, cancer antigens, interleukins, and cytokines.
Why does protein folding matter?
In this video, Sengenics demonstrate the importance of protein folding and how immunoprofiling with Sengenics Microarrays can deliver actionable results.
Advanced proteomics tools bring us one step closer to precision medicine
Discover how Sengenics’ protein microarray technology improves the reproducibility, specificity and biological relevance of proteomic assays
The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection
Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections
Enhancing biomarker analysis with bioinformatics: lessons in an emerging field
The head of bioinformatics at Sengenics reveals more about the emerging field of bioinformatics, and how the knowledge gained can be applied to enhance immunoprofiling to find meaningful biomarker signatures
Autoantibodies: The key to early diagnosis and improved patient stratification
Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
